Edwards Lifesciences Corporation (EW) Financials

EW Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 ? ?
March 31, 2026 13.3 billion 3.0 billion
Dec. 31, 2025 13.7 billion 3.4 billion
Sept. 30, 2025 13.3 billion 3.1 billion

EW Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 ? ?
March 31, 2026 -21.1 million 45.4 million
Dec. 31, 2025 353.5 million 39.2 million
Sept. 30, 2025 516.2 million 41.2 million

EW Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 ?
March 31, 2026 380.7 million
Dec. 31, 2025 91.2 million
Sept. 30, 2025 290.3 million

EW Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 - - -
March 31, 2026 3.7 billion 598.5 million 80.1 million
Dec. 31, 2025 4.2 billion 598.3 million 82.6 million
Sept. 30, 2025 3.8 billion 598.2 million 75.3 million

EW Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 577.6 million
March 31, 2026 580.7 million
Dec. 31, 2025 581.8 million
Sept. 30, 2025 585.7 million

EW Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 278.9 million 561.2 million -
March 31, 2026 64.9 million 263.3 million 522.2 million -
Dec. 31, 2025 97.4 million 267.7 million 602.9 million -
Sept. 30, 2025 57.5 million 280.7 million 514.6 million -

EW Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.7 billion 390.6 million
March 31, 2026 1.6 billion 359.3 million
Dec. 31, 2025 1.6 billion 340.6 million
Sept. 30, 2025 1.6 billion 345.2 million

EW Revenue by Segment
Graph available only for paid members. Upgrade to see it.

EW

Price: $84.24

52 week price:
72.30
96.29

Earnings Per Share: 1.68 USD

P/E Ratio: 51.05

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 2.2 million

Ebitda: 328.1 million

Market Capitalization: 49.0 billion

Links: